Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Disability in late-life major depression: patterns of self-reported task abilities, task habits, and observed task performance.

Rogers JC, Holm MB, Raina KD, Dew MA, Shih MM, Begley A, Houck PR, Mazumdar S, Reynolds CF 3rd.

Psychiatry Res. 2010 Aug 15;178(3):475-9. doi: 10.1016/j.psychres.2009.11.002.

2.

Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.

Drevets WC, Furey ML.

Biol Psychiatry. 2010 Mar 1;67(5):432-8. doi: 10.1016/j.biopsych.2009.11.021. Epub 2010 Jan 15.

3.

Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer's Disease Cooperative Study Group.

Neurology. 2009 Jun 16;72(24):2115-21. doi: 10.1212/WNL.0b013e3181aa52d3.

4.

Patterns of mild cognitive impairment after treatment of depression in the elderly.

Bhalla RK, Butters MA, Becker JT, Houck PR, Snitz BE, Lopez OL, Aizenstein HJ, Raina KD, DeKosky ST, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2009 Apr;17(4):308-16. doi: 10.1097/JGP.0b013e318190b8d8.

5.

Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study.

Steffens DC, McQuoid DR, Potter GG.

J Geriatr Psychiatry Neurol. 2009 Mar;22(1):52-61. doi: 10.1177/0891988708328213. Epub 2009 Feb 4.

6.

Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.

Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.

Neurology. 2009 May 5;72(18):1555-61. doi: 10.1212/01.wnl.0000344650.95823.03. Epub 2009 Jan 28.

PMID:
19176895
7.

Safety and efficacy of galantamine in subjects with mild cognitive impairment.

Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS; GAL-INT-11/18 Study Group.

Neurology. 2008 May 27;70(22):2024-35. doi: 10.1212/01.wnl.0000303815.69777.26. Epub 2008 Mar 5. Erratum in: Neurology. 2010 Oct 19;75(16):1485.

PMID:
18322263
8.

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Pelton GH, Harper OL, Tabert MH, Sackeim HA, Scarmeas N, Roose SP, Devanand DP.

Int J Geriatr Psychiatry. 2008 Jul;23(7):670-6.

9.

A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.

Holtzheimer PE 3rd, Meeks TW, Kelley ME, Mufti M, Young R, McWhorter K, Vito N, Chismar R, Quinn S, Dey S, Byrd EH, McDonald WM.

Int J Geriatr Psychiatry. 2008 Jun;23(6):625-31.

10.

Donepezil for the treatment of agitation in Alzheimer's disease.

Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, Jones RW, DeCesare J, Rodger M; CALM-AD Trial Group.

N Engl J Med. 2007 Oct 4;357(14):1382-92.

11.

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J; Group for the Study of Resistant Depression.

J Clin Psychiatry. 2007 Jul;68(7):1062-70.

PMID:
17685743
12.

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.

Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R.

Lancet Neurol. 2007 Jun;6(6):501-12. Erratum in: Lancet Neurol. 2007 Oct;6(10):849.

PMID:
17509485
13.

Persistence of neuropsychologic deficits in the remitted state of late-life depression.

Bhalla RK, Butters MA, Mulsant BH, Begley AE, Zmuda MD, Schoderbek B, Pollock BG, Reynolds CF 3rd, Becker JT.

Am J Geriatr Psychiatry. 2006 May;14(5):419-27.

PMID:
16670246
14.

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.

Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D.

Arch Gen Psychiatry. 2006 May;63(5):530-8.

15.

Maintenance treatment of major depression in old age.

Reynolds CF 3rd, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ.

N Engl J Med. 2006 Mar 16;354(11):1130-8.

16.

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group.

N Engl J Med. 2005 Jun 9;352(23):2379-88. Epub 2005 Apr 13.

17.

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.

Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S; Donepezil 401 Study Group.

Neurology. 2004 Aug 24;63(4):651-7.

PMID:
15326237
18.

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A, Pandita-Gunawardena ND, Hogg F, Clare C, Damms J.

Neurology. 2004 Jul 27;63(2):214-9.

PMID:
15277611
19.

The nature and determinants of neuropsychological functioning in late-life depression.

Butters MA, Whyte EM, Nebes RD, Begley AE, Dew MA, Mulsant BH, Zmuda MD, Bhalla R, Meltzer CC, Pollock BG, Reynolds CF 3rd, Becker JT.

Arch Gen Psychiatry. 2004 Jun;61(6):587-95.

PMID:
15184238
20.

A rating scale for depression.

HAMILTON M.

J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62. No abstract available.

Supplemental Content

Support Center